Document Report Card

Basic Information

ID: ALA1821631

Journal: Bioorg Med Chem Lett

Title: A novel binding assay identifies high affinity ligands to the rosiglitazone binding site of mitoNEET.

Authors: Geldenhuys WJ, Funk MO, Awale PS, Lin L, Carroll RT.

Abstract: A novel outer mitochondrial membrane protein containing [2Fe-2S] clusters, mitoNEET was first identified through its binding to the anti-diabetic drug pioglitazone. Pioglitazone belongs to a family of drugs that are peroxisome proliferator-activated receptor (PPAR) gamma agonists, collectively known as glitazones. With the lack of pharmacological tools available to fully elucidate mitoNEET's function, we developed a binding assay to probe the glitazone binding site with the aim of developing selective and high affinity compounds. We used multiple thiazolidine-2,4-dione (TZD), 2-thioxothiazolidin-4-one (TTD), and 2-iminothiazolidin-4-one (ITD) compounds to establish several trends to enhance ligand development for the purpose of elucidating mitoNEET function.

CiteXplore: 21782425

DOI: 10.1016/j.bmcl.2011.06.111